These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11092263)

  • 1. HLA-A2 subtype in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
    Kakizaki S; Takagi H; Murakami M; Takayama H; Sato K; Mori M
    Liver; 2000 Oct; 20(5):423-4. PubMed ID: 11092263
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
    Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune thyroid disease induced by interferon therapy].
    Murakami M; Kakizaki S; Takayama H; Takagi H; Mori M
    Nihon Rinsho; 1999 Aug; 57(8):1779-83. PubMed ID: 10483250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the IFN-alpha-related thyroid autoimmunity an immunologically heterogeneous disease?
    Mazziotti G; Sorvillo F; Carbone A; Cioffi M; Morisco F; Carella C
    J Intern Med; 2002 Oct; 252(4):377-8; author reply 379. PubMed ID: 12366611
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
    Kakizaki S; Takagi H; Murakami M; Takayama H; Mori M
    J Hepatol; 1999 May; 30(5):794-800. PubMed ID: 10365804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha and autoimmune thyroid disease.
    Prummel MF; Laurberg P
    Thyroid; 2003 Jun; 13(6):547-51. PubMed ID: 12930598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis C virus infection and thyroid diseases].
    Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
    Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.
    Hsieh MC; Yu ML; Chuang WL; Shin SJ; Dai CY; Chen SC; Lin ZY; Hsieh MY; Liu JF; Wang LY; Chang WY
    Eur J Endocrinol; 2000 May; 142(5):431-7. PubMed ID: 10802518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined interferon alpha and ribavirin therapy on thyroid functions in patients with chronic hepatitis C.
    Nadeem A; Aslam M; Khan DA; Hussain T; Khan SA
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):86-9. PubMed ID: 19208310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-titre auto-antibodies predict autoimmune disease during interferon-alpha treatment of chronic hepatitis C.
    Bell TM; Bansal AS; Shorthouse C; Sandford N; Powell EE
    J Gastroenterol Hepatol; 1999 May; 14(5):419-22. PubMed ID: 10355504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
    Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic hepatitis C complicated with thyroid disease by peginterferon alfa-2a: 3 cases report].
    Yu SJ; Geng H; Chen LM; Lv S; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):69. PubMed ID: 21272468
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemolytic anemia secondary to alpha-interferon treatment in a patient with chronic C hepatitis.
    de-la-Serna-Higuera C; Bárcena-Marugán R; Sanz-de-Villalobos E
    J Clin Gastroenterol; 1999 Jun; 28(4):358-9. PubMed ID: 10372938
    [No Abstract]   [Full Text] [Related]  

  • 15. [The linkage of the major histocompatibility complex to autoimmune thyroid diseases].
    Tamai H; Matsubayashi S; Kimura A
    Nihon Rinsho; 1999 Aug; 57(8):1710-5. PubMed ID: 10483238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid autoimmunity and dysfunction associated with type I interferon therapy.
    Monzani F; Caraccio N; Dardano A; Ferrannini E
    Clin Exp Med; 2004 Apr; 3(4):199-210. PubMed ID: 15103510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune thyroid disease and rheumatoid arthritis: relationship and the role of genetics.
    Lazúrová I; Jochmanová I; Benhatchi K; Sotak S
    Immunol Res; 2014 Dec; 60(2-3):193-200. PubMed ID: 25427993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies.
    Löhr HF; Schmitz D; Arenz M; Weyer S; Gerken G; Meyer zum Büschenfelde KH
    J Hepatol; 1999 Sep; 31(3):407-15. PubMed ID: 10488697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1).
    Hass HG; Klein R; Nehls O; Kaiser S
    J Clin Gastroenterol; 2009; 43(5):470-6. PubMed ID: 19247202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection.
    Alric L; Izopet J; Fort M; Vinel JP; Fontenelle P; Orfila C; Payen JL; Sandres K; Desmorat H; Charlet JP; Duffaut M; Abbal M
    Hum Immunol; 1999 Jun; 60(6):516-23. PubMed ID: 10408801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.